Literature DB >> 7232421

Treatment of chemically-induced intestinal cancers with indomethacin.

M Pollard, P H Luckert.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7232421     DOI: 10.3181/00379727-167-41142

Source DB:  PubMed          Journal:  Proc Soc Exp Biol Med        ISSN: 0037-9727


× No keyword cloud information.
  8 in total

Review 1.  Aspirin, NSAIDs, and digestive tract cancers.

Authors:  M J Thun
Journal:  Cancer Metastasis Rev       Date:  1994-12       Impact factor: 9.264

2.  Effect of aspirin and NSAIDs on colorectal adenomas. Protective effect may be spurious.

Authors:  S V Lo; H U Perry; R Lyons
Journal:  BMJ       Date:  1993-09-18

3.  Aspirin and risk of fatal colon cancer.

Authors:  G P Morgan; J G Williams
Journal:  Postgrad Med J       Date:  1993-11       Impact factor: 2.401

Review 4.  Nonsteroidal antiinflammatory agents in chemoprevention of colorectal cancer. At what cost?

Authors:  M A Trujillo; H S Garewal; R E Sampliner
Journal:  Dig Dis Sci       Date:  1994-10       Impact factor: 3.199

5.  Similarity of colorectal cancer in Crohn's disease and ulcerative colitis: implications for carcinogenesis and prevention.

Authors:  P M Choi; M P Zelig
Journal:  Gut       Date:  1994-07       Impact factor: 23.059

Review 6.  The cancer stem cell: evidence for its origin as an injured autoreactive T cell.

Authors:  Peter Grandics
Journal:  Mol Cancer       Date:  2006-02-14       Impact factor: 27.401

7.  Effects of cimetidine and indomethacin on the growth of dimethylhydrazine-induced or transplanted intestinal cancers in the rat.

Authors:  A Caignard; M Martin; D Reisser; B Thomas; F Martin
Journal:  Br J Cancer       Date:  1984-11       Impact factor: 7.640

8.  Preparation and Characterization of Indomethacin Supramolecular Systems with β-Cyclodextrin in Order to Estimate Photostability Improvement.

Authors:  Marzena Jamrógiewicz; Marek Józefowicz
Journal:  Molecules       Date:  2021-12-08       Impact factor: 4.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.